Trial Profile
A phase I/II study of Lonsurf combined with Oxaliplatin in metastatic colorectal cancer patients refractory to standard chemotherapy.
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 13 Mar 2019
Price :
$35
*
At a glance
- Drugs Oxaliplatin (Primary) ; Tipiracil/trifluridine (Primary)
- Indications Adenocarcinoma; Colorectal cancer
- Focus Adverse reactions; Therapeutic Use
- Acronyms LUPIN study
- 06 Mar 2019 Results published in the Investigational New Drugs
- 29 Nov 2018 Status changed from active, no longer recruiting to completed.
- 01 Nov 2018 Status changed from recruiting to active, no longer recruiting.